Updated Jul 16, 2026
Spiegel Robert J. has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Robert J. Spiegel is a corporate director associated with RenovoRx, Inc. and Geron Corporation. He has been involved in the biopharmaceutical sector, particularly in companies focused on cancer treatment.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | GERN | GERON CORP | A — Grant or award | 6.1K | $1.28 | $8K |
| 2026-04-01 | GERN | GERON CORP | A — Grant or award | 5.2K | $1.49 | $8K |
| 2025-09-30 | GERN | GERON CORP | A — Grant or award | 5.7K | $1.37 | $8K |
| 2025-06-30 | GERN | GERON CORP | A — Grant or award | 5.5K | $1.41 | $8K |
| 2024-10-01 | GERN | GERON CORP | A — Grant or award | 1.8K | $0.00 |
Robert J. Spiegel is a corporate director associated with RenovoRx, Inc. and Geron Corporation. He has been involved in the biopharmaceutical sector, particularly in companies focused on cancer treatment.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Spiegel Robert J. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.